Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway microbiology
Several large clinical trials have approved the use of cyclin-dependent kinase (CDK) 4/6 inhibitors such as abemaciclib (ABM), palbociclib, and […]